TOPAMAC Side Effects

6766694-0 | Abasia, Coordination Abnormal, Epilepsy
on Jun 04, 2010 Male patient from COLOMBIA , child 3 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Topamac (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, coordination abnormal, epilepsy (What is epilepsy?). Topamac dosage: . During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ).

6558509-0 | Psychotic Disorder
Patient was taking Topamac (View Usage). Patient had the following side effects: psychotic disorder (What is psychotic disorder?) on Jan 21, 2010 from GREECE Additional patient health information: Female patient , 35 years of age, was diagnosed with migraine (What is migraine?) and. Topamac dosage: .

6191163-9 | Neoplasm Malignant
Adverse event was reported on May 11, 2009 by a Female patient taking Topamac (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: COLOMBIA , 63 years of age, After Topamac was administered, patient had the following side effects: neoplasm malignant. During the same period patient was treated with RISPERDAL CONSTA (View Risperdal Consta Review and Risperdal Consta Label ).

6123381-X | Angle Closure Glaucoma
on Mar 10, 2009 Female patient from COLOMBIA , 28 years of age, was diagnosed with migraine prophylaxis and was treated with Topamac (View Usage). Patient experienced the following unwanted or unexpected effects: angle closure glaucoma. Topamac dosage: .


5854133-3 | Blood Creatinine Increased, Renal Failure
on Aug 15, 2008 Male patient from URUGUAY , 68 years of age, was diagnosed with essential tremor, prostatic disorder and was treated with Topamac (View Usage). Patient had the following side effects: blood creatinine increased, renal failure. Topamac dosage: . During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5691982-9 | White Blood Cell Count Decreased
Patient was taking Topamac (View Usage). After Topamac was administered, patient had the following side effects: white blood cell count decreased on Mar 27, 2008 from GREECE Additional patient health information: Female patient , 26 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Topamac dosage: .

5469441-8 | Agoraphobia
Adverse event was reported on Sep 18, 2007 by a Female patient taking Topamac (View Usage) (Dosage: ) was diagnosed with partial seizures and. Location: COLOMBIA , child 4 years of age, Patient experienced the following unwanted or unexpected effects: agoraphobia.

5338060-6 | Bronchospasm, Tachycardia
on May 21, 2007 Female patient from ARGENTINA , 32 years of age, weighting 242.5 lb, was diagnosed with overweight, glucose tolerance impaired, bipolar disorder (What is bipolar disorder?) and was treated with Topamac (View Usage). Patient had the following side effects: bronchospasm, tachycardia. Topamac dosage: . During the same period patient was treated with T4 (View T4 Review and T4 Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), ROSIGLITAZONE (View Rosiglitazone Review and Rosiglitazone Label ).

5239473-3 | Hypotonia
on Feb 09, 2007 Male patient from INDIA , child 5 years of age, was diagnosed with convulsion and was treated with Topamac (View Usage). After Topamac was administered, patient had the following side effects: hypotonia. Topamac dosage: .

5227576-9 | Amnesia, Memory Impairment, Mutism, Speech Disorder
Patient was taking Topamac (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, memory impairment, mutism, speech disorder on Jan 31, 2007 from ARGENTINA Additional patient health information: Female patient , 64 years of age, weighting 160.9 lb, was diagnosed with epilepsy (What is epilepsy?) and. Topamac dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

5221135-X | Amnesia, Memory Impairment, Mutism, Speech Disorder
Adverse event was reported on Jan 18, 2007 by a Female patient taking Topamac (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: ARGENTINA , 64 years of age, weighting 160.9 lb, Patient had the following side effects: amnesia, memory impairment, mutism, speech disorder. During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

5211631-3 | Amnesia, Memory Impairment, Mutism, Speech Disorder
on Jan 09, 2007 Female patient from ARGENTINA , 64 years of age, weighting 160.9 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Topamac (View Usage). After Topamac was administered, patient had the following side effects: amnesia, memory impairment, mutism, speech disorder. Topamac dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

5081722-9 | Gastritis Erosive, Oesophagitis
on Aug 01, 2006 Male patient from ARGENTINA , child 9 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Topamac (View Usage). Patient experienced the following unwanted or unexpected effects: gastritis erosive, oesophagitis. Topamac dosage: . During the same period patient was treated with CLONAZEPAN (View Clonazepan Review and Clonazepan Label ). Patient was hospitalized.

5072460-7 | Gastritis Erosive, Oesophagitis
Patient was taking Topamac (View Usage). Patient had the following side effects: gastritis erosive, oesophagitis on Jul 26, 2006 from ARGENTINA Additional patient health information: Male patient , child 9 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Topamac dosage: . During the same period patient was treated with CLONAZEPAN (View Clonazepan Review and Clonazepan Label ). Patient was hospitalized.